Men’s Health
RALEIGH, N.C. - By his own reckoning, a Navy electrician spent just eight hours in Vietnam, during a layover on his flight back to the U.S.
NEW YORK - Wooden toy rattles and video baby monitors are among the recalled products in this week's roundup.
NEW YORK - Medicare administrators say they will take a full year to review Dendreon Corp.'s prostate cancer therapy Provenge and decide whether to cover the costly treatment.
NEW YORK - Medicare administrators say they will take a full year to review Dendreon Corp.'s prostate cancer therapy Provenge and decide whether to cover the costly treatment.
More News
- FDA approves Sanofi-Aventis prostate cancer drug
- Cancer wins may be bigger than they seem
- Analysis: Cancer wins may be bigger than they seem
- FDA approves new drug for advanced prostate cancer
- FDA approves breakthrough cancer therapy Provenge
- FDA approves Dendreon's cancer drug Provenge
- Mylan starts shipping generic version of Flomax
- Study finds possible heart risk with prostate drug
- GSK receives EU approval for prostate drug
- Va fined $227K for flawed cancer treatments in Pa.
- Va Dept. fined $227K for flawed cancer treatments
- Sanofi drug shows promise against prostate cancer
- Cancer society casts more doubt on prostate tests
- Amgen sees positive data in bone drug study
- Vivus reports positive data on ED drug candidate
- Auxilium drug meets penile curvature study goal
- AEterna Zentaris says prostate drug fails in study
- Recall news
- SC WWII vet's battle ends in gunshot at VA clinic
- GlaxoSmithKline pulls application for new drug use
- Business Highlights
